BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
SPHERIX (NQ: SPEX)
1.910 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(SPEX) Community Analysis from
April 20, 2014
(Jutia Group, 3/28/14)
[at noodls] - Exhibit 99.2 - Sues Cisco for Patent Infringement. Spherix seeks damages andassertsthat over $43 billion of Cisco'ssales infringe on...(read more)
(, 4/17/12)
We recommend investors keep an eye on Spherix, Inc. (SPEX). The stock has a history of quick rallies on news, followed by quick sell-offs on subsequent dilutive financings. The company has several...(read more)
Courtesy of Benzinga Spherix Incorporated (NASDAQ: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis;...(read more)
Spherix (SPEX) Company Overview

There is no analysis for SPEX yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here